当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 现金流量表

泰格医药

(300347)

  

流通市值:312.55亿  总市值:475.29亿
流通股本:5.66亿   总股本:8.61亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,034,062,055.587,252,500,492.855,317,979,3333,377,830,010.85
  收到的税费返还2,677,768.2318,708,343.1314,560,502.32478,422.27
  收到其他与经营活动有关的现金53,706,326.07100,557,127.0681,749,437.4544,497,393.35
  经营活动现金流入小计2,090,446,149.887,371,765,963.045,414,289,272.773,422,805,826.47
  购买商品、接受劳务支付的现金654,921,629.082,385,493,371.311,592,666,205.03983,894,406.19
  支付给职工以及为职工支付的现金811,053,535.183,201,531,424.162,363,815,844.11,602,792,496.76
  支付的各项税费111,725,928.93391,733,866.32320,605,174.81203,828,742.69
  支付其他与经营活动有关的现金195,041,280.33274,922,530.71397,644,419.26223,671,172.89
  经营活动现金流出小计1,772,742,373.526,253,681,192.54,674,731,643.23,014,186,818.53
  经营活动产生的现金流量净额317,703,776.361,118,084,770.54739,557,629.57408,619,007.94
二、投资活动产生的现金流量:
  收回投资收到的现金353,734,657.822,190,670,618.941,777,634,145.311,029,475,120.59
  取得投资收益收到的现金118,504,208.43639,151,660.33165,736,772.121,077,608.36
  处置固定资产、无形资产和其他长期资产收回的现金净额275,166.525,933,203.192,139,573.132,016,439
  收到的其他与投资活动有关的现金-67,746,984.3117,128,630.276,423,003.84
  投资活动现金流入小计472,514,032.772,903,502,466.771,962,639,120.811,058,992,171.79
  购建固定资产、无形资产和其他长期资产支付的现金50,430,337.37214,369,102.48173,581,867.91100,831,158.12
  投资支付的现金338,564,515.281,915,690,187.331,138,161,366.31874,389,321.69
  取得子公司及其他营业单位支付的现金400,000164,946,844.98115,646,821.752,258,635.58
  支付其他与投资活动有关的现金28,882,924.28116,939,779.7541,542,266.8235,623,000
  投资活动现金流出小计418,277,776.932,411,945,914.541,468,932,322.791,013,102,115.39
  投资活动产生的现金流量净额54,236,255.84491,556,552.23493,706,798.0245,890,056.4
三、筹资活动产生的现金流量:
  吸收投资收到的现金114,736,849.16223,654,000162,098,00092,600,000
  其中:子公司吸收少数股东投资收到的现金---92,600,000
  取得借款收到的现金234,127,7001,137,864,305.841,044,986,871.591,009,796,907.23
  收到其他与筹资活动有关的现金-60,576,00061,200,000-
  筹资活动现金流入小计348,864,549.161,422,094,305.841,268,284,871.591,102,396,907.23
  偿还债务支付的现金158,269,636.32,373,696,294.12,170,230,969.651,235,205,515.51
  分配股利、利润或偿付利息支付的现金14,967,990.38343,659,038.48341,108,089.3288,157,666.74
  其中:子公司支付给少数股东的股利、利润---16,655,591.75
  支付其他与筹资活动有关的现金168,051,754.39631,424,182.78441,734,176.59405,984,045.92
  筹资活动现金流出小计341,289,381.073,348,779,515.362,953,073,235.541,929,347,228.17
  筹资活动产生的现金流量净额7,575,168.09-1,926,685,209.52-1,684,788,363.95-826,950,320.94
四、汇率变动对现金及现金等价物的影响-14,454,893.77-8,841,588.412,935,487.0814,360,075.82
五、现金及现金等价物净增加额365,060,306.52-325,885,475.16-448,588,449.28-358,081,180.78
  加:期初现金及现金等价物余额1,722,608,377.682,048,493,852.842,048,493,852.842,048,493,852.84
  期末现金及现金等价物余额2,087,668,684.21,722,608,377.681,599,905,403.561,690,412,672.06
补充资料:
  净利润-805,056,174.52-362,828,303.84
  资产减值准备-37,043,406.56-29,310,150.71
  固定资产和投资性房地产折旧-133,420,590.25-64,363,418.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-133,420,590.25-64,363,418.85
  无形资产摊销-78,338,419.78-40,155,429
  长期待摊费用摊销-42,809,046.7-21,241,046.6
  处置固定资产、无形资产和其他长期资产的损失--3,650,548.27--625,757.46
  固定资产报废损失-1,089,100.07--
  公允价值变动损失--42,256,274.39-89,643,957.92
  财务费用-107,509,287.27-69,211,216.51
  投资损失--433,815,899.7--233,000,832.99
  递延所得税--48,218,232.93--25,274,854.86
  其中:递延所得税资产减少--18,142,797.11--7,790,596.03
    递延所得税负债增加--30,075,435.82--17,484,258.83
  存货的减少--9,516,013.06--21,172,493.35
  经营性应收项目的减少--199,801,117.54--229,911,780.62
  经营性应付项目的增加-511,487,999.77-151,014,505.74
  其他-23,680,964.04-32,109,629.89
  现金的期末余额-1,722,608,377.68-1,690,412,672.06
  减:现金的期初余额-2,048,493,852.84-2,048,493,852.84
  现金及现金等价物的净增加额--325,885,475.16--358,081,180.78
公告日期2026-04-292026-03-312025-10-292025-08-29
审计意见(境内)标准无保留意见
TOP↑